Professional Documents
Culture Documents
ORAL
dr. Theodorus, MMedSc
Staf Bagian Farmakologi
FK Unsri
ATP
Channel
Glucose
ATP
Metabolism
Binding
Sulfonylurea
Insulin
Secretion
Ca trigger
Ca
Passive flux
Voltage
Ca
Channel
Sulfonylurea
K
VDCC
ATP
or
VDCC
ATP
Ca2+
ATP
K+
Depolarization
Resting celll
Stimulated cell
SULFONILUREA
1.
2.
3.
Generasi I :
Carbutamide
Tolbutamide
Chlorpropamide
Generasi II :
Glyburide = glyclaside
Glipizide
Generasi III :
Glimepiride
Mechanism of action Thiazolidinediones
SULFONILUREA
SIDE EFFECTS
Hypoglicemic reactions including coma
Particularly, elderly patients with impaired hepatic or renal function
Glyburide=chlorpropamide > glipizide > tolbutamide
Nausea and Vomiting
Aplastic and hemolytic anemia
Hypersensitivity and dermatological reactions
SULFONIL UREA
CONTRAINDICATIONS
Hypersensitivity
Diabetic keto acidosis
DRUG INTERACTION
Clofibrate, dicumarol, salysilates displace the sulfonyl
ureas from binding site
SECRETAGOGUE LAIN
MEGLITINIDES :
1. Repaglinide
2. Meglitinide
3. Nateglinide
BIGUANIDE (METFORMIN)
Increase glucose uptake in striated muscle
Inhibit hepatic glucose output & intestinal
glucose absorbtion
Cause anorexia assist in weight loss
Are used with sulphonylurea when these have
ceased to work adequately
Reduction of total cholesterol, LDL cholesterol
& trigliceride
Increase HDL cholesterol concentration
4. Liver : Hepatic
Glucose Output
Metformin HGO
METFORMIN
DRUG INTERACTION
Cimetidine and furosemide increased the metformin
plasma
Alcohol potentiate the effect of metformin
ACARBOSE
SIDE EFFECTS: usually during the first
week of therapy; most commonly mild-tomoderate GI tracts such as flatulance,
diarrhea, and abdominal discomport
CONTRAINDICATION:
- Hypersensitifity
- Diabetic ketoacidosis
- Cirrhosis
THIAZOLIDINEDIONES
Antidiabetic agents that increase insuline
sensitivity through the modulation of several
processes
These agents affect:
- insulin receptor kinase activity
- insulin receptor phosphorylation
- insulin receptor numbers
- hepatic glucose metabolism
May activate PPAR- (Peroxisome Proliferator
Activated Receptor) in adipose tissue, skeletal
muscle and liver
Improve
cell function
Thiazolidinedione
PPAR
RXR
mRNA
Response
elements
Promoter
Gene transcription
Coding Region
Nucleus
TZD
CONTRAINDICATION
- Hypersensitivity
- Liver disease
- Pregnancy category C
- Nursing woman
DRUG INTERACTION
- May induce drug metabolism by CYP3A4:
Consider this when prescribing with others
CYP3A4 substrate such as CCB, cisapride,
steroid and HMG-CoA reductase inhibitors
GLIPTINE
DPP-4 inhibitors (Dipeptidyl peptidase-4)
Linagliptin, sitagliptin, vilda and
saxagliptin
Mechanism of action: enhance and prolong
the action of incretin hormones by
competitively antagonizing the enzyme
DPP-4
gliptin
Pharmakokinetics
Rapidly absorbed after oral administration,
with peak plasma concentration occuring
in 1- 4 hours
Bioavaibility is more than 87%
79% is excreted unchanged in the urine,
primarily via renal excretion
Only slightly is metabolized by using
CYP3A4 and CYP2C6 in liver
gliptin
CONTRINDICATION
DM type 1
Hipersensitivity
Pregnancy
SIDE EFFECTS
Upper respiratory tract infection
Headache, nausea
Hypersensitivity reaction
gliptin
DRUG INTERACTION:
Alpha adrenergic agonist, isoniazid,
antipsychotic first generation reduced its
effect
Etanol and quinolone enhanced its effect